Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 28,997 | 27,136 | 19,082 | 17,077 | 15,598 |
| Cost of Goods | 16,020 | 15,735 | 12,018 | 10,464 | 8,110 |
| Gross Profit | 12,977 | 11,401 | 7,064 | 6,613 | 7,488 |
| Operating Expenses | 46,707 | 36,113 | 31,257 | 30,601 | 40,307 |
| Operating Income | -33,710 | -23,977 | -24,175 | -23,524 | -32,709 |
| Interest Expense | 1,789 | 0 | 0 | 0 | 267 |
| Other Income | -51,936 | 98,912 | 467 | 438 | 34,238 |
| Pre-tax Income | -87,435 | 74,935 | -23,708 | -23,086 | 1,262 |
| Net Income Continuous | -87,435 | 74,935 | -23,708 | -23,086 | 1,262 |
| Net Income | $-87,435 | $74,935 | $-23,708 | $-23,086 | $1,262 |
| EPS Basic Total Ops | -0.45 | 0.46 | -0.14 | -0.15 | 0.01 |
| EPS Basic Continuous Ops | -0.45 | 0.46 | -0.14 | -0.15 | 0.01 |
| EPS Diluted Total Ops | -0.45 | 0.45 | -0.14 | -0.15 | 0.01 |
| EPS Diluted Continuous Ops | -0.45 | 0.45 | -0.14 | -0.15 | 0.01 |
| EBITDA(a) | $-30,675 | $-21,593 | $-21,823 | $-21,346 | $-30,297 |